NCT07250061 Self-Help Cognitive Processing Therapy (CPT)/Women Veterans Network (WoVeN) Study
| NCT ID | NCT07250061 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Boston University |
| Condition | Posttraumatic Stress Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-03-05 |
| Primary Completion | 2028-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-03-05 with a primary completion date of 2028-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Posttraumatic stress disorder (PTSD) can have significant impairment on aspects of mental well-being (MWB) including functioning, loneliness, physical health, and quality of life. There are several evidence-based treatments (EBPs) effective in treating PTSD such as Cognitive Processing Therapy (CPT) which is a specific type of cognitive behavioral therapy that has been proven effective in reducing symptoms of PTSD. However, there are several barriers (e.g., lack of providers, waitlists, costs, stigma, disabilities that complicate travel) that can prevent someone from engaging with these treatments. Recently, a self-help version of CPT was created to help address these barriers; but little research has been conducted to test its efficacy. Further, less is know about how a peer support program may augment improvements from participating in an EBP. The Women Veteran Network (WoVeN), a peer support program designed for women veterans, has a manualized 8-week program that directly targets MWB. It has been found to help foster belongingness and connectedness, particularly in those suffering from PTSD and depression. The present study aims to establish the feasibility, acceptability and tolerability of a scalable, sustainable, and effective treatment option for trauma survivors with subthreshold or full PTSD. The overarching goal is to understand the effectiveness of a self-help version of an EBP (either alone or in combination with a peer support program) in reducing PTSD symptoms while also helping improve mental well-being, reduce barriers, and increase access to quality care within health disparity populations.
Eligibility Criteria
Inclusion Criteria: * Identifies as a woman * Has served in the United States military * A full or subthreshold (meets criteria for 2 out of 4 of the symptom clusters for PTSD) Post Traumatic Stress Disorder (PTSD) diagnosis * Able to read English well enough to complete study questionnaires Exclusion Criteria: * Clinician judgment that the participant is not appropriate for self-help level of care for PTSD (i.e., recent psychiatric hospitalization, requires detox, volatile, active suicidality) * Current psychosis or unstable bipolar disorder (determined during baseline interview as described in screening and enrollment procedures) * Must not have participated in a WoVeN group within the last year * Must not be receiving an evidenced-based therapy for PTSD at the time of the screening
Contact & Investigator
Tara E Galovski, PhD
PRINCIPAL INVESTIGATOR
BUCA School of Medicine, Psychiatry and VA Medical Center
Frequently Asked Questions
Who can join the NCT07250061 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Posttraumatic Stress Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07250061 currently recruiting?
Yes, NCT07250061 is actively recruiting participants. Contact the research team at Tara.Galovski@va.gov for enrollment information.
Where is the NCT07250061 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT07250061 clinical trial?
NCT07250061 is sponsored by Boston University. The principal investigator is Tara E Galovski, PhD at BUCA School of Medicine, Psychiatry and VA Medical Center. The trial plans to enroll 100 participants.